• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

    4/19/24 12:28:35 PM ET
    $COIN
    $GIII
    $ORIC
    $TDG
    Finance: Consumer Services
    Finance
    Apparel
    Consumer Discretionary
    Get the next $COIN alert in real time by email

    Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.

    Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance to uncover new information.

    This index layers editorial commentary to help make sense of why these stocks should be of interest and whether investors or casual readers should watch them.

    Related Link: The ‘Mag 7 Bench' – Josh Brown Picks The Next Magnificent 7 Stocks

    Here is a look at the Benzinga Stock Whisper Index for the week of April 19:

    Coinbase Global (NASDAQ:COIN): The cryptocurrency trading platform saw increased interest as the company’s shares pulled back during the trading week. The drop in share price could be related to a drop in the price of Bitcoin (CRYPTO: BTC) from all-time highs set earlier this year.

    Bitcoin remains volatile ahead of the highly anticipated Bitcoin halving. High volatility for cryptocurrencies like Bitcoin can be positive for Coinbase as it increases its trading volume activity.

    Oric Pharmaceuticals (NASDAQ:ORIC): The clinical stage biotechnology company saw increased interest in its shares during the week. The increased attention comes after the company announced that the first patients for its expansion cohorts of Phase 1b trial of ORIC-114 have been dosed. The expansion of ORIC-114 is targeting non-small cell lung cancer. Oric said it plans to update Phase 1b data in the first half of 2025.

    SPDR Gold Trust (NYSE:GLD): It's not every week that an ETF jumps in interest and trends on the Stock Whisper Index. The leading gold ETF saw increased interest, which comes as gold soars to new all-time highs in the month of April. A decision by the Federal Reserve to keep interest rates the same and increased geopolitical tension related to the Middle East have led to more attention to gold as a safe haven investment for traders.

    G-III Apparel Group (NASDAQ:GIII): The apparel company saw shares trade lower after reporting quarterly results. Fourth-quarter sales were down 10.5% year-over-year to $764.8 million, which missed a Street consensus estimate of $817.5 million. The company owns and licenses brands that include Clavin Klein, Tommy Hilfiger, DKNY and Donna Karan. G-III guided for fiscal year 2025 sales to hit $3.2 billion, in-line with the Street estimate.

    Transdigm Group (NYSE:TDG): The maker of components for aircraft and other vehicles saw increased interest over the trading week. The increased attention likely comes from new analyst notes. A Goldman Sachs analyst, who has a Buy rating, raised the price target on shares from $1,218 to $1,518.

    Meanwhile, a Stifel analyst kept a Hold rating during the week, but raised the price target from $1,100 to $1,200. Shares of Transdigm trade at $1,213.50 at the time of writing. The company could also be seeing increased attention as it makes parts for military aircraft. Defense stocks have been in the spotlight with increased geopolitical tensions and calls to increase military aid for allies overseas.

    Stay tuned for next week's report, and follow Benzinga Pro for all the latest headlines and top market-moving stories here.

    Read the latest Stock Whisper Index reports here:

    March 22

    March 29

    April 12

    Read Next: EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In March: Where Do Tesla, Nvidia, SPY And Reddit IPO Rank?

    Get the next $COIN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $COIN
    $GIII
    $ORIC
    $TDG

    CompanyDatePrice TargetRatingAnalyst
    Coinbase Global Inc.
    $COIN
    4/8/2026$140.00Equal Weight → Underweight
    Barclays
    Transdigm Group Incorporated
    $TDG
    4/1/2026$1200.00Equal Weight
    Wells Fargo
    G-III Apparel Group LTD.
    $GIII
    3/13/2026$34.00 → $29.00Market Perform
    Telsey Advisory Group
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    Transdigm Group Incorporated
    $TDG
    2/5/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    Transdigm Group Incorporated
    $TDG
    2/4/2026$1400.00Outperform → Neutral
    Robert W. Baird
    Coinbase Global Inc.
    $COIN
    1/28/2026$240.00Neutral
    Robert W. Baird
    Coinbase Global Inc.
    $COIN
    1/27/2026$277.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $COIN
    $GIII
    $ORIC
    $TDG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Haas Alesia J

    4 - Coinbase Global, Inc. (0001679788) (Issuer)

    4/20/26 4:29:52 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Reiss Joel

    4 - TransDigm Group INC (0001260221) (Issuer)

    4/16/26 4:57:51 PM ET
    $TDG
    Military/Government/Technical
    Industrials

    SEC Form 4 filed by Palmer Peter

    4 - TransDigm Group INC (0001260221) (Issuer)

    3/23/26 4:31:34 PM ET
    $TDG
    Military/Government/Technical
    Industrials

    $COIN
    $GIII
    $ORIC
    $TDG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.976 Million Tokens, and Total Crypto and Total Cash Holdings of $12.9 Billion

    Bitmine now owns more than 4% of the total ETH coin supply of 120.7 millionBitmine is 82% of the way to the 'Alchemy of 5%' in just 9 monthsEthereum continues to benefit from the dual tailwinds of Wall Street tokenizing on theblockchain and from agentic AI systems increasingly needing public and neutralblockchainsBitmine uplisted to the New York Stock Exchange ("NYSE") from the NYSE Americaneffective as of April 9, 2026Bitmine has 3,334,637 staked ETH, representing $7.7 billion at $2,301 per ETHMAVAN (Made in America VAlidator Network) is a premier Ethereum staking destinationfor BMNR and institutional investors, with a focus on security, performance, andresilienceBitmine owns $107 million o

    4/20/26 8:30:00 AM ET
    $BMNR
    $COIN
    $MSTR
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting

    SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 17, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of multiple poster presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting highlighting the potential of rinzimetostat (ORIC-944), a potent and selective allosteric inhibitor of PRC2 to treat prostate cancer. The posters can be found in the publication section of ORIC's website here. "Our research continues to show the therapeutic potential of PRC2 inhibition across the prostate cancer dise

    4/17/26 4:05:00 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Starfighters Space Partners with Blackstar Orbital for Hypersonic Testing Platform as Space Sector Prepares for Historic SpaceX Public Debut

    CAPE CANAVERAL, Fla., April 15, 2026 (GLOBE NEWSWIRE) -- As SpaceX prepares for what could become the largest IPO in history with its confidential S-1 filing targeting a $1.75 trillion valuation and June roadshow, space infrastructure companies are positioning for sector-wide growth. Starfighters Space, Inc. (NYSE:FJET), owner and operator of the world's largest commercial supersonic aircraft fleet, has announced a strategic partnership with Blackstar Orbital to advance flight testing of revolutionary reusable hypersonic space systems. The March 26 Technical Interchange Agreement (TIA), unveiled at the Satellite 2026 conference, establishes a framework for integrating Blackstar's innovati

    4/15/26 10:44:18 AM ET
    $ASTS
    $FJET
    $GE
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Consumer Electronics/Appliances

    $COIN
    $GIII
    $ORIC
    $TDG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Coinbase Global downgraded by Barclays with a new price target

    Barclays downgraded Coinbase Global from Equal Weight to Underweight and set a new price target of $140.00

    4/8/26 8:26:44 AM ET
    $COIN
    Finance: Consumer Services
    Finance

    Wells Fargo initiated coverage on Transdigm Group with a new price target

    Wells Fargo initiated coverage of Transdigm Group with a rating of Equal Weight and set a new price target of $1,200.00

    4/1/26 8:55:10 AM ET
    $TDG
    Military/Government/Technical
    Industrials

    Telsey Advisory Group reiterated coverage on G-III Apparel with a new price target

    Telsey Advisory Group reiterated coverage of G-III Apparel with a rating of Market Perform and set a new price target of $29.00 from $34.00 previously

    3/13/26 8:22:27 AM ET
    $GIII
    Apparel
    Consumer Discretionary

    $COIN
    $GIII
    $ORIC
    $TDG
    SEC Filings

    View All

    Transdigm Group Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    8-K - TransDigm Group INC (0001260221) (Filer)

    4/17/26 4:15:13 PM ET
    $TDG
    Military/Government/Technical
    Industrials

    SEC Form 144 filed by Coinbase Global Inc.

    144 - Coinbase Global, Inc. (0001679788) (Subject)

    4/16/26 2:53:39 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    Transdigm Group Incorporated filed SEC Form 8-K: Regulation FD Disclosure

    8-K - TransDigm Group INC (0001260221) (Filer)

    4/15/26 7:14:29 AM ET
    $TDG
    Military/Government/Technical
    Industrials

    $COIN
    $GIII
    $ORIC
    $TDG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Small Robert J bought $1,285 worth of shares (1 units at $1,285.00) (SEC Form 4)

    4 - TransDigm Group INC (0001260221) (Issuer)

    2/27/26 4:22:59 PM ET
    $TDG
    Military/Government/Technical
    Industrials

    President & CEO Lisman Michael bought $1,220,048 worth of shares (950 units at $1,284.26), increasing direct ownership by 41% to 3,259 units (SEC Form 4)

    4 - TransDigm Group INC (0001260221) (Issuer)

    2/9/26 4:30:19 PM ET
    $TDG
    Military/Government/Technical
    Industrials

    President & CEO Lisman Michael bought $2,616,674 worth of shares (1,954 units at $1,339.14) (SEC Form 4)

    4 - TransDigm Group INC (0001260221) (Issuer)

    11/17/25 4:30:19 PM ET
    $TDG
    Military/Government/Technical
    Industrials

    $COIN
    $GIII
    $ORIC
    $TDG
    Leadership Updates

    Live Leadership Updates

    View All

    ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones

    Announced rinzimetostat (ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with AR inhibitors Presented potential best-in-class enozertinib Phase 1b data demonstrating highly competitive systemic and intracranial activity in NSCLC patients with EGFR exon 20 and EGFR PACC mutations; selected Phase 3 monotherapy dose Raised $244 million from top-tier healthcare specialist funds; Cash and investments of $413 million expected to provide runway into 2H 2028 and beyond anticipated primary endpoint readout for rinzimetostat Phase 3 study Expect to report multiple cli

    1/12/26 8:30:00 AM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates

    Announced completion of dose exploration portion of ORIC-944 Phase 1b clinical trial and presented data that continues to demonstrate potential best-in-class efficacy and safety Bolstered leadership team with the appointment of Kevin Brodbeck, PhD, as Chief Technical Officer to further support ORIC's transition to potential late-stage development Cash and investments of approximately $413 million expected to provide runway into 2H 2028 and beyond anticipated primary endpoint readouts from first Phase 3 trials for ORIC-944 and enozertinib (ORIC-114) Expects to report four clinical data readouts across ORIC-944 and enozertinib (ORIC-114) programs through mid-2026, ahead of potential initiat

    11/13/25 4:10:00 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Citi and Coinbase Join Forces to Boost Digital Asset Payment Capabilities for Global Clients

    Citi and Coinbase are collaborating to develop digital asset payment capabilities for institutional clients The collaboration will first focus on streamlining fiat pay-ins/pay-outs and payments orchestration, enhancing the bridge between traditional and digital finance for Coinbase's on/off ramps Specific initiatives will be shared in the coming months, as Citi and Coinbase explore options to simplify and expand access to digital asset payments for Citi's clients Today, Citi and Coinbase announced their intention to collaborate on digital asset payment capabilities for Citi's institutional clients and explore additional global clients in the future, further solidifying both compan

    10/27/25 12:00:00 PM ET
    $C
    $COIN
    Major Banks
    Finance
    Finance: Consumer Services

    $COIN
    $GIII
    $ORIC
    $TDG
    Financials

    Live finance-specific insights

    View All

    Coinbase Announces Date of First Quarter 2026 Financial Results

    Coinbase Global, Inc. (the "Company" or "Coinbase") announced today that it will release its first quarter 2026 financial results on Thursday, May 7, 2026, after market close. The Company will hold a webcast to discuss its financial results at 2:30 p.m. PT that same day. The live webcast of the call can be accessed here. Following the call, a replay of the call, as well as a transcript, will be available on the Investor Relations website at investor.coinbase.com. Disclosure Information In addition to filings with the Securities and Exchange Commission, the Company uses its Investor Relations website (investor.coinbase.com), its blog (blog.coinbase.com), press releases, public conferen

    4/13/26 5:53:00 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.803 Million Tokens, and Total Crypto and Total Cash Holdings of $11.4 Billion

    Bitmine has been approved for uplisting to the New York Stock Exchange ("NYSE") from the NYSE American effective at the opening of trading on April 9, 2026Bitmine has 3,334,637 staked ETH, representing $7.1 billion at $2,123 per ETHMAVAN (Made in America VAlidator Network) is the premier Ethereum staking destination for BMNR and institutional investors, with a focus on security, performance, and resilienceBitmine now owns 3.98% of the ETH token supply, over 79% of the way to the 'Alchemy of 5%' in just 9 monthsBitmine owns $92 million of ORBS, now one of the only publicly listed equities in the world to give investors direct exposure to OpenAIBitmine Crypto + Total Cash Holdings + "Moonshots

    4/6/26 8:30:00 AM ET
    $BMNR
    $COIN
    $MSTR
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    ORIC® Pharmaceuticals Reports Selection of Rinzimetostat RP3D in Combination with Darolutamide for Himalayas-1 Phase 3 Global Study with Dose Optimization Data Supporting Its Potential Best-in-Disease Profile

    Rinzimetostat 400 mg once daily selected as RP3D in combination with darolutamide for Himalayas-1 global Phase 3 registrational trial in post-abiraterone mCRPC, with initiation expected in 1H 2026 At a median follow-up of ~5 months, landmark 5-month rPFS of 84% is consistent with competitor PRC2 inhibitor and substantially better than standard of care therapies in mCRPC Highly differentiated, potential best-in-disease safety profile, with significantly lower frequency and severity of adverse events, nearly all Grade 1 or 2, and far fewer treatment modifications than competitor regimens Company to host a conference call and webcast today at 4:30 pm ET SOUTH SAN FRANCISCO, Calif. and SAN D

    3/31/26 4:05:00 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $COIN
    $GIII
    $ORIC
    $TDG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Oric Pharmaceuticals Inc.

    SC 13G/A - Oric Pharmaceuticals, Inc. (0001796280) (Subject)

    11/14/24 5:54:12 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Oric Pharmaceuticals Inc.

    SC 13G/A - Oric Pharmaceuticals, Inc. (0001796280) (Subject)

    11/14/24 5:47:31 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Coinbase Global Inc.

    SC 13G/A - Coinbase Global, Inc. (0001679788) (Subject)

    11/14/24 5:44:24 PM ET
    $COIN
    Finance: Consumer Services
    Finance